Tetra Bio-Pharma’s drug ARDS-003 has been cleared by the FDA for human trials to target sepsis and ARDS. IT has been months in the making, but biopharmaceutical company Tetra Bio-Pharma has received the green light from the US Food and Drug Administration (FDA) to begin a Phase 1 trial with human subjects for its investigational [ ]
The post A novel treatment for cytokine storm appeared first on Health Europa.
Saturday 6 March 2021
Latest News
